LAAx Overview

  • Founded
  • 2006
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $27.6M
Latest Deal Amount

LAAx General Information


Manufacturer of medical occlusion equipment. The company develops TigerPaw System that occludes the left atrial appendage (LAA) and confirms to its shape and thickness, minimizing the risk of tissue damage and accidental bleeding associated with other common closing methods used during open chest procedures.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 151 Lindbergh Avenue
  • Suite I
  • Livermore, CA 94551
  • United States
+1 (925) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LAAx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Merger/Acquisition 21-May-2013 $27.6M 000.00 Completed Generating Revenue
To view LAAx’s complete valuation and funding history, request access »

LAAx Executive Team (1)

Name Title Board Seat Contact Info
Bill Wheeler Chief Executive Officer & President
To view LAAx’s complete executive team members history, request access »